V
Véronique Préat
Researcher at Université catholique de Louvain
Publications - 351
Citations - 26431
Véronique Préat is an academic researcher from Université catholique de Louvain. The author has contributed to research in topics: Drug delivery & Electroporation. The author has an hindex of 73, co-authored 332 publications receiving 22534 citations. Previous affiliations of Véronique Préat include University College London & Catholic University of Leuven.
Papers
More filters
Journal ArticleDOI
PLGA-based nanoparticles: An overview of biomedical applications
Fabienne Danhier,Eduardo Ansorena,Joana M. Silva,Joana M. Silva,Régis Coco,Aude Le Breton,Véronique Préat +6 more
TL;DR: This review presents why PLGA has been chosen to design nanoparticles as drug delivery systems in various biomedical applications such as vaccination, cancer, inflammation and other diseases.
Journal ArticleDOI
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
TL;DR: Delivery of conventional chemotherapeutic anti-cancer drugs is mainly discussed and exploitation and the understanding of these characteristics to design new drug delivery systems targeting the tumor are focused on.
Journal ArticleDOI
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach.
TL;DR: Vaccines are certainly the most promising applications for orally delivered nanoparticles and encouraging results upon in vivo testing are reported but low bioavailability and lack of control on absorbed dose slow down products development.
Journal ArticleDOI
RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis.
TL;DR: This review aims to particularly highlight the position of RGD-based nanoparticles in cancer therapy and imaging and the binding of the RGD peptide to this integrin.
Journal ArticleDOI
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation
Fabienne Danhier,Nathalie Lecouturier,Benoît Vroman,Christine Jérôme,Jacqueline Marchand-Brynaert,Olivier Feron,Véronique Préat +6 more
TL;DR: PTX-loaded nanoparticles showed greater tumor growth inhibition effect in vivo on TLT tumor, compared with Taxol, and may be considered as an effective anticancer drug delivery system for cancer chemotherapy.